Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00003955 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003955 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma |
| Official title | A Phase II "Up-Front Window Study" of Irinotecan (CPT-11) Followed by Multimodal, Multiagent, Therapy for Selected Children and Adolescents With Newly Diagnosed Stage 4/Clinical Group IV Rhabdomyosarcoma: An IRS-V Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | dactinomycin, filgrastim, pegfilgrastim, sargramostim, cyclophosphamide, irinotecan hydrochloride, vincristine sulfate, radiation therapy |
| Enrollment | 77 |
| Start date | Sep 1, 1999 |
| Primary completion | Jan 1, 2005 |
| Completion | Oct 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 14, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: